Table 4. Description of the TCGA PRAD cohort.
| Features | Total Cases |
|---|---|
| Cohort | 497 patients |
| Tumour | 497 |
| Normal | 52 (w/tumour matched
sample available) |
| Gleason grade | |
| 6 | 50 |
| 7 | 287 |
| 8 | 67 |
| 9 | 140 |
| 10 | 4 |
| Tumour stage | |
| T2a | 14 |
| T2b | 10 |
| T2c | 192 |
| T3a | 173 |
| T3b | 140 |
| T4 | 12 |
| Gleason grade (alternative gleason grade
grouping) | |
| 1 (primary +
secondary score ≤ 6) |
50 |
| 2 (3 + 4) | 171 |
| 3 (4 + 3) | 123 |
| 4 (4 + 4) | 93 |
| 5 (primary +
secondary score ≥ 9) |
111 |
All tumours were hormone naive (not subject to ADT) at the time of sample collection